Purchase Order 75F40123P00166

The Food and Drug Administration awarded a purchase order to Firalis Molecular Precision SA for $56,042.50 on July 24, 2023, for miRNA whole transcriptome assay service in human plasma samples. No set-aside applied. Work is performed in Huningue, France. The order has a firm fixed price and an ultimate completion date of November 30, 2023.